DURECT Corp (DRRX) to Offer Common Stock

DURECT Corporation (Nasdaq: DRRX) announced that it is commencing an underwritten public offering of its common stock (the "Offering"). All of the shares to be sold in the Offering will be sold by DURECT, subject to customary closing conditions. In addition, DURECT intends to grant the underwriter for the Offering a 30-day option to purchase up to an additional 15% of the number of shares of its common stock offered in the public offering.

Cantor Fitzgerald & Co. is acting as the sole book running manager for the Offering.

You May Also Be Interested In

• Nuvation Bio prices $250M convertible notes offering due 2032
• Definium Therapeutics raises $805M in upsized public offering
• ProQR prices $50M share offering with Eli Lilly joining as buyer